Arrowhead Pharmaceuticals (MEX:ARWR) Ending Cash Position: MXN955 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ARWR Arrowhead Pharmaceuticals Inc MEX:ARWR
45 GF Score
Price MXN454.55
GF Value MXN312.20
! 6 Warning Signs
View Full Analysis

What is Arrowhead Pharmaceuticals Ending Cash Position?

Arrowhead Pharmaceuticals MEX:ARWR 45 Ending Cash Position is MXN955 Mil as of Jun. 2026. GuruFocus rates MEX:ARWR with a GF Score™ of 45/100 and a GF Value™ of MXN312.20. The stock has 6 warning signs investors should review.

Arrowhead Pharmaceuticals's Ending Cash Position for the quarter that ended in Jun. 2026 was MXN955 Mil.

Arrowhead Pharmaceuticals's quarterly Ending Cash Position declined from Dec. 2025 (MXN3,631 Mil) to Mar. 2026 (MXN3,399 Mil) and declined from Mar. 2026 (MXN3,399 Mil) to Jun. 2026 (MXN955 Mil).

Arrowhead Pharmaceuticals's annual Ending Cash Position increased from Sep. 2023 (MXN1,932 Mil) to Sep. 2024 (MXN2,022 Mil) and increased from Sep. 2024 (MXN2,022 Mil) to Sep. 2025 (MXN4,156 Mil).

Arrowhead Pharmaceuticals Ending Cash Position Related Terms

Arrowhead Pharmaceuticals Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Arrowhead Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arrowhead Pharmaceuticals Ending Cash Position Chart

Arrowhead Pharmaceuticals Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,792.33 2,172.52 1,931.60 2,021.90 4,155.84

Arrowhead Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,443.90 4,155.84 3,630.72 3,399.47 955.49
MEX:ARWR
45GF Score
Arrowhead Pharmaceuticals Inc MEX:ARWR
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arrowhead Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Arrowhead Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Sep. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1883.674+2272.168
=4,156

Arrowhead Pharmaceuticals's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=3289.434+-2333.944
=955

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of MXN955 Mil mean?
Arrowhead Pharmaceuticals (MEX:ARWR) has a Ending Cash Position of MXN955 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Arrowhead Pharmaceuticals and its competitors.
Is Arrowhead Pharmaceuticals' Ending Cash Position too high?
Arrowhead Pharmaceuticals' current Ending Cash Position is MXN955 Mil. Overall, Arrowhead Pharmaceuticals has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Arrowhead Pharmaceuticals' Ending Cash Position compare to AXSM and MDGL?
Arrowhead Pharmaceuticals' Ending Cash Position of MXN955 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Arrowhead Pharmaceuticals and its competitors. Arrowhead Pharmaceuticals's current Ending Cash Position is MXN955 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arrowhead Pharmaceuticals stock overvalued right now?
Arrowhead Pharmaceuticals (MEX:ARWR) has a current Ending Cash Position of MXN955 Mil. The stock's GF Value™ is MXN312.20, compared to a current price of MXN454.55 — trading 45.6% above its estimated fair value. The current Ending Cash Position is MXN955 Mil. Arrowhead Pharmaceuticals' overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Arrowhead Pharmaceuticals (MEX:ARWR), the current Ending Cash Position is MXN955 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arrowhead Pharmaceuticals (MEX:ARWR) Overvalued in 2026?

Based on GuruFocus' analysis, Arrowhead Pharmaceuticals stock appears to be overvalued. The current stock price of MXN454.55 is trading 45.6% above its estimated GF Value™ of MXN312.20.

Key valuation signals for MEX:ARWR:

  • Ending Cash Position: MXN955 Mil
  • GF Value™: MXN312.20 vs. price of MXN454.55 (45.6% above fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the MEX:ARWR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arrowhead Pharmaceuticals Business Description

Address 177 E Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
45GF Score

Get the complete analysis for MEX:ARWR

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN454.55
Price
MXN312.20
GF Value